Fig. 1
From: Ruxolitinib improves symptoms and quality of life in a patient with systemic mastocytosis
QLQ-C30 Functional scales (a) and combined symptoms score (b)
Advertisement
Fig. 1 | Biomarker Research
Advertisement
From: Ruxolitinib improves symptoms and quality of life in a patient with systemic mastocytosis
QLQ-C30 Functional scales (a) and combined symptoms score (b)
